BACKGROUND Few studies have explored percutaneous coronary intervention (PCI) in perioperative myocardial
M yocardial infarction is a serious complication in the post-operative setting in many patients undergoing noncardiac surgery. Current estimates put the incidence of perioperative myocardial infarction (PMI) at 5% within 30 days, with most events occurring within 48 h after major surgery (1) . Considering the fact that >200 million patients throughout the world undergo major noncardiac surgery every year, these estimates are of paramount clinical significance (2) . The American College of Cardiology/American Heart Association (ACC/AHA) and European guidelines on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery focus on prevention and detection of PMI; however, specific recommendations on effective management of PMI are not available due to a paucity of data (3, 4) .
Numerous risk models have been developed
to predict adverse cardiovascular outcomes after noncardiac surgery, using well-recognized surgery and patient-specific variables. These predictive models enable risk stratification and risk mitigation, but they are of little value when ischemia and infarction are actually encountered in the post-operative setting.
Although the role of revascularization in the acute coronary syndrome setting is well established, performance of percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery in the early post-operative setting is challenging due to patient comorbidities and relatively higher bleeding risk. PCI performance requires the mandatory use of adjunctive potent antithrombotic and antiplatelet therapies. Major bleeding especially in the nonaccess site has been consistently associated with poor shortand long-term outcomes in multiple PCI datasets (5) .
As a result, data on outcomes in this high-risk patient population are scant. To overcome this variables. All variables were entered into the model, and backward selection was done using stepwise regression technique (7).
All statistical tests were 2-tailed, and confidence limits (CLs) were reported at 95% level (p < 0.05 was considered significant). (8) . Figure 2 shows the type of surgery patients underwent prior to presentation to the catheterization laboratory.
RESULTS
Vascular (29%), pelvic (14%) and gastrointestinal surgeries (14%) together constituted surgeries performed for more than one-half of the patient population presenting with PMI to the catheterization laboratory. Disposition of the study population after index coronary angiography is shown in Table 3 .
TIME-EVENT ANALYSIS OF THE STUDY POPULATION.
Using Kaplan-Meier survival analysis, we determined 30-day mortality was 5.2% and 1-year mortality was 15% in the overall population. In the PCI subpopulation, we estimated 30-day mortality to be 11.3% Table 2 shows mortality (reported as %) in PCI and no PCI subgroups of the study population (mortality was derived as:
The Central Illustration shows overall mortality curve for the patients who underwent PCI with- Semiparametric multivariate Cox proportional hazard analysis was also performed to determine the predictors of long-term mortality in the study population.
Stepwise modeling was carried out using the back- (Figure 7 ).
Online Figure 1 shows the number of patients who underwent coronary angiography within 7 days after noncardiac surgery and also the numbers of patients who were ultimately converted to PCI stratified by years, indicating that there was no change in trend of conversion to PCI over time (p trend ¼ 0.20).
Online Figure 2 shows Kaplan-Meir analysis of PCI *A total of 25.7% patients underwent PCI. Most patients had no culprit lesion to intervene upon. These patients experienced perioperative MI secondary to demand and supply imbalance during the perioperative period. 6.7% patients actually had severe CAD, who, in the best judgment of the operating interventionist and consulting surgeon, were candidates for coronary artery bypass grafting. Also, 5.7% of patients were considered to be at too great a risk for bleeding and, according to the best judgment of the operating interventionist, would benefit from delayed PCI (beyond the 7 days after surgery cutoff, and therefore not included in our study).
CAD ¼ coronary artery disease; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention. population stratified by STEMI and NSTEMI status.
Online Table 3 shows a descriptive analysis of eight patients found to have stent thrombosis as the culprit for perioperative STEMI at the time of index PCI.
DISCUSSION
Our study provides clinicians with valuable information in regard to all-cause mortality in the overall group as well as the pre-specified subgroups following MI complicating noncardiac surgery. Multivariate analysis revealed the independent predictors of both 30-day and long-term all-cause mortality. We have also described important interventional characteristics in this patient population, including culprit vessel, intraprocedural medication use, and lesion grade. To our knowledge, this is the first study describing the lesion characteristics observed by the operator in the catheterization laboratory as well as both the short-and long-term predictors of mortality in patients treated with PCI after PMI. NSTEMI (in 85% of patients) was the dominant cause of PMI with a specific diagnosis of STEMI identified only in 15% of patients. Almost one-third of patients with PMI underwent a vascular surgery procedure in the previous week, indicating the high-risk nature of most procedures in this setting (9) . It is well known that any form of vascular surgery predisposes to myocardial ischemia more than any other form of surgery in general (10, 11) . This is a consequence of increased blood loss leading to tachycardia, which in turn is the most common cause of post-operative oxygen supply-demand imbalance (12) . shows mortality (%) at fixed time intervals for the PCI population, stratified by STEMI and NSTEMI status. As described in the Results section, 30 days' mortality is markedly high. (B) Vascular surgery, bleeding, and renal insufficiency were major predictors of long-term mortality, hence we plotted 1-year mortality rates of the PCI subset of our population stratified by vascular surgery versus no vascular surgery (B1), bleeding in index hospitalization versus no bleeding (B2), and renal insufficiency status (B3). PCI ¼ percutaneous coronary intervention; NSTEMI ¼ non-ST-segment elevation myocardial infarction.
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contributes to mortality (13) . This adverse event is compounded by aspirin therapy and other antiplatelet agents especially in patients who have previously undergone revascularization. Vascular surgery was associated with significantly higher mortality rate. Abbreviation as in Figure 1 . Renal insufficiency was associated with significantly higher mortality rate. Abbreviation as in Figure 1 . However, the role of PCI as a treatment modality is unclear partly due to a lack of quality data on outcomes in these patients (17) . Although there is some evidence that preoperative revascularization leads to decreased post-operative cardiac enzyme elevations, this does not translate into a direct mortality benefit (18). Bleeding was associated with significantly higher mortality rate. Abbreviation as in Figure 1 . .006
.001
.004
Bleeding event, peak troponin T level, and peripheral vascular disease predict mortality within 30 days of PCI in this patient population. CL ¼ confidence limit; HR ¼ hazard ratio.
Parashar et al. Furthermore, in several studies, it was shown that a decreased level of kidney function is an independent risk factor for all-cause mortality (20, 21) . In addition, the high prevalence of combined coronary artery disease and peripheral vascular disease has been confirmed in multiple studies (22, 23) . This is not surprising considering the common risk factors for atherosclerosis involved in pathogenesis of both. Therefore, the presence of peripheral vascular disease in predicting an adverse outcome after PMI was a reasonable hypothesis, which in this case turns out to be true.
STUDY LIMITATIONS. Our study is an observational study and therefore inherently lacks the strength of a randomized controlled trial. We acknowledge the potential for referral bias and selection bias as many PMI patients were managed medically and never made it to the catheterization laboratory. Notably, the primary source of data for this study was the coronary angiography database prospectively maintained at our institution. It is not possible for us to accurately distinguish patients who had perioperative MI who did not undergo angiography, as this population is not captured in our databases. Moreover, the definition of PMI varies widely in published reports and is very dynamic, with ever-changing guidelines.
We have chosen a definition which, in our opinion, most accurately reflects the clinical picture at our institution. We used stepwise regression methods as Older age, vascular surgery, bleeding events, and renal dysfunction strongly predict long-term mortality after PCI in the setting of PMI. CL ¼ confidence limit; HR ¼ hazards ratio; PMI ¼ perioperative myocardial infarction; other abbreviation as in Figure 1 . Parashar et al.
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